November 13, 2023 /

Overview of Topline Results from Phase 3 EMBARK Study

PPMD was joined by Crystal Proud, MD for a community webinar on November 8th at 1 PM ET to discuss the recently shared Phase 3 topline results of the EMBARK study (SRP-9001-301). Siobhan Fitzgerald, Executive Director of Patient Affairs at Sarepta Therapeutics, also joined the webinar to answer frequently asked questions related to plans moving forward.

Posted on November 13, 2023

Join Our Mailing List